Fact CheckerSign in

NCT07798167Active, not recruiting

Tuberculosis Sentinel Research Network (TB-SRN)

Source: ClinicalTrials.gov · Last updated 13 Oct 2026

Brief summary (registry, in English)

The overarching objective/aim of the study is to assess pulmonary TB treatment and longer-term outcomes among people with and without HIV in African population in order to inform policy and practice around TB treatment and create a platform for additional TB research in Zambia

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
374 (actual)
First submitted
18 Aug 2026
Start date
15 Sept 2022
Primary completion date
22 Dec 2026
Lead sponsor
Centre for Infectious Disease Research in Zambia
Diseases
Tuberculosis
NCT number
NCT07798167

What you commit to

  • Study type: Observational
  • Participants enrolled: 374
  • From 15 Sept 2022 to the primary completion date, 22 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • 1\. Received \>1 week of TB treatment within the prior 30 days, excluding TB preventive therapy

Other illness

  • 3\. Have substantial cognitive impairment that in the opinion of the site investigator or designee may interfere with the ability to give reliable informed consent

Other

  • Have plans to follow-up for TB care at a site distant from the enrollment site, imminent plans to move from his/her current area of residence, or plans to return to a distant area of residence, which would interfere with the participant's ability to complete all study visits (through the 12-month post-treatment visit).

Who the study is looking for

  • 1\. Be ≥15 years of age
  • Clinically diagnosed pulmonary TB and initiated/to be initiated on anti-TB treatment, as determined by medical providers through standard of care, on the basis of either.
  • Microbiologically confirmed pulmonary TB based on sputum or other respiratory samples with either

Age in the registry: 15 years to 99 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Chawama and Kanyama General Hospitals
Coordinator of this site? Confirm its status
LusakaZambiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.